Intel Valuation

Intel (INTC) has been an out of favor stock for over a year now. The company’s share price had a recent peak in April 2021 at $68 and is now trading around $27. This is quite the move for a large cap stock, let alone one of the largest semiconductor companies in the world. Intel designs and manufactures CPUs and other integrated circuits for PCs, data center, AI, and autonomous vehicles.

One of the main reasons Intel has sold off is due to their inability to manufacture the cutting edge transistors. This has led to their competitor AMD to gain market share since they utilize Taiwan Semiconductor to manufacture their chips. Additionally, demand for semiconductors have recently softened, which has led to most semiconductor stocks to face drawdowns. Given all this negative sentiment around Intel, I decided to perform a rough valuation to see if it is a candidate for my portfolio.

The valuation approach I will use is a simplified “earnings power” valuation from Bruce Greendwald’s valuation book. The first step is to figure out a reasonable steady state revenue. In 2021, INTC did $79B in revenue, which is an all time high. However this year Intel has lowered their guidance, estimating revenue coming in around $65B. Using this year’s guidance, plus the last four years of revenue, Intel’s average revenue comes to $73B, which I will use for this analysis.

Next is operating margins. Over the past 10 years, Intel operating margins have hovered between 33% and 25%. For this analysis I’ll use 30% as a steady state operating margin. This produces $21.9B in operating earnings based on my $73B revenue figure.

Greenwald’s earnings power valuation uses an after tax earnings. Philips typically pays an effective tax rate of around 20%. This tax rate applied to the $21.9B in operating earnings produces an after tax earnings of $17.52B.

The next step is to capitalize the after tax earnings with a reasonable cost of capital to arrive at the estimated enterprise value. Looking at historical P/E ratios, INTC has varied between 18 and it’s current value of 6. Seeing that Intel is a large cap stock with strong earnings, but still rough around the edges, I think a 7% cost of capital is reasonable.

By dividing the cost of capital by the post-tax earnings, we get the enterprise value of the company. Capitalizing the $17.52B in earnings by 7% produces an enterprise value of $250.3B. INTCs current enterprise value is around $120B. From these rough calculations, it appears there is a margin of safety in Intel’s shares. 

Since Intel looks promising, I’ll go ahead and calculate the estimated fair value of its shares. To go from enterprise value to equity value, first the cash balance of $28.4B is added back. Next, the short and long term debts are subtracted, which are currently $4.6B and $33.5B respectively. This produces an estimated equity value of $240.6B, and dividing by 4.09M shares outstanding produces a share price of $58.80. 

Since Intel definitely looks cheap on paper, I want to continue to do more due diligence. One thing that is concerning is Intel’s inability to produce the cutting edge transistors, thus losing market share. I would like to study the issue more and see if Intel has a chance of regaining superiority in CPUs. Additionally, I’ve heard Intel is slated to spend a large amount of money on capital expenditures. I would be interested to know what all that money is going towards, and whether it will produce much growth for the company. Intel definitely has some challenges ahead, but the stock price does seem compelling as long as the fundamentals do not deteriorate significantly in the future.

Philips Valuation

In this post, I want to do a rough valuation of Koninklijke Philips (the ADR ticker is PHG). Philips provides healthcare imaging solutions, medical records solutions, respirators and other medical devices, as well as personal care devices such as electric toothbrushes and shavers. The company’s stock price hit a high around $61 in April 2021, and then proceeded to slide down ever since to the current price of around $18. It seems that a reason for this decline is due to a recall of respirators. I usually like to buy out of favor stocks due to some scandal or other temporary ailment, so PHG seemed right up my alley.

I recently read Bruce Greenwald’s Valuation book, and have been applying his different valuation approaches to the companies I am interested in. Here I will do a simplified “earnings power” valuation from the book. The first step is to figure out a reasonable revenue estimate going forward. In 2021, PHG did $19.5B in revenue, which is quite a bit down from the 2020 print of $23.8B. Looking at the past several years of revenue, Philips has not grown much, so a reasonable revenue estimate I’m using is $22B a year.

Next is operating margins. Over the past 10 years, Philips has had operating margins as low as 2.3% and as high as 9.5%. Usually margins are around 8% but there are a few bad years. For this analysis I’ll use 7% as a steady state operating margin. This produces $1,540M in operating earnings based on my $22B revenue figure.

Greenwald’s earnings power valuation uses an after tax earnings. Philips typically pays an effective tax rate of around 30%. This tax rate applied to the $1,540M in operating earnings produces an after tax earnings of $1,080M.

The next step is to capitalize the after tax earnings with a reasonable cost of capital to arrive at the estimated enterprise value. Looking at PHGs bond yields shows an average interest rate of around 6%. Another data point I use is to look at historical P/E ratios. Here, some of the average annual P/E ratios are very high, mainly due to low earnings that year and I guess the stock price did not decline much. Even with removing these outliers, the historical P/E has varied between 17 and 35, with an average around 20. Since the 6% cost of debt is higher than the historical earnings yield, I’ll stick with the more conservative rate of 6% (even though I feel like this value seems low). 

By dividing the cost of capital by the post-tax earnings, we get the enterprise value of the company. Capitalizing the $1,080M in earnings by 6% produces an enterprise value of $18B. PHGs current enterprise value is $23B…so clearly the stock is still overpriced. Unfortunately, even though Philips has had a large drawdown, I am not seeing any margin of safety based on reasonable assumptions on what the business can produce. Therefore, Philips is a pass, but at least it provided a good valuation exercise.